Biogen Archives - Pharmaphorum

Merck KGaA’s BTK drug reduces lesions in relapsing MS patients

https://pharmaphorum.com/news/merck-kgaas-btk-drug-reduces-lesions-in-relapsing-ms-patients/

NICE in talks with Biogen after rejecting SMA drug

https://pharmaphorum.com/news/nice-in-talks-with-biogen-after-rejecting-sma-drug/

Biogen and Eisai Alzheimer’s drug excites doctors, but not investors

https://pharmaphorum.com/news/biogen-and-eisai-alzheimers-drug-excites-doctors-but-not-investors/

PureTech to research Alzheimer’s drugs based on ‘brain drain’ theory

https://pharmaphorum.com/news/puretech-research-alzheimers-brain-drain-theory/

AbbVie’s Orilissa gets FDA nod as Humira competition looms

https://pharmaphorum.com/news/abbvies-orlissa-gets-fda-nod-as-humira-competition-looms/

Hope for Alzheimer’s treatment after promising study results

https://pharmaphorum.com/news/alzheimers-disease-promising-study/

PTC shares soar after SMA drug data impresses market

https://pharmaphorum.com/news/ptc-therapeutics-posts-solid-sma-data/

Biogen’s Alzheimer’s drug, elenbecestat, shows early promise

https://pharmaphorum.com/news/biogens-alzheimers-drug-elenbecestat/

vTv’s azeliragon is latest Alzheimer’s drug failure

https://pharmaphorum.com/news/vtvs-azeliragon-latest-alzheimers-drug-failure/

Search